期刊文献+

不同血液净化方式对慢性肾衰竭血液透析患者β_2-微球蛋白、瘦素清除率及透析充分性的影响 被引量:20

Nutrion status and quality of life and clearance rate of serum β_2-microglobulin and leptin in maintainance hemodialysis patients of different dialysis modalities
下载PDF
导出
摘要 目的探讨血液透析、血液透析滤过和血液灌流3种透析方式对维持性血液透析患者血清β_2-微球蛋白(β_2-MG)和瘦素的清除率、透析相关并发症发生率、营养状况及透析充分性的影响。方法42例维持性血液透析患者分为血液透析组、血液透析滤过组和血液灌流组,观察首次透析前后及透析6个月后β_2-MG和瘦素的浓度与清除率、透析相关并发症发生率及血清白蛋白、血红蛋白、体重指数的变化以及透析充分性质量评分。结果血液透析组首次透析前后血清β_2-MG和瘦素浓度无变化;血液透析滤过组和血液灌流组首次透析后血清β_2-MG和瘦素浓度较透析前降低(P<0.05);透析6个月后,血液透析滤过组和血液灌流组血清β_2-MG和瘦素浓度较血液透析组低(P<0.05);血液透析滤过组和血液灌流组首次透析后血清β_2-MG和瘦素清除率高于血液透析组(P<0.05);血液透析滤过组和血液灌流组经6个月透析治疗后血清白蛋白、血红蛋白、体重指数高于血液透析组(P<0.05)。透析过程中,血液透析滤过组和血液灌流组常见并发症发生率低于血液透析组(P<0.05),透析充分性质量评分高于血液透析组(P<0.05)。结论血液透析滤过和血液灌流两种血液净化方式比血液透析模式能较好地清除尿毒症患者体内中分子毒素,能明显减少透析相关并发症发生率,改善营养状况,提高透析充分性,改善生存质量。 Objective To study the clearance of serum β2-microglobulin (β2-MG) and serum leptin, the nutrition status, the rates of dialysis complication and the quality of life scores in maintaninance hemodialysis patients of different dialysis modalities. Methods 42 hemodialysis patients, whose health status are similar, were divided into hemodialysis group (HD), hemodiafiltration and hemodialysis group (HDF&HD) and hemoperfusion and hemodialysis group (HP&HD). The serum albumin, hemoglobin, body mass index, the clearance rate of serum β2-MG and leptin were measured after treatment. The rates of dialysis complication and quality of life scores were measured. Results Serum β2-MG and leptin were significantly lower after HDF&HD and HP&HD (P 〈0.05), but not after HD in single treatment and 6 months treatment. The clearance rate of β2-MG and leptin in group HDF&HD and HP&HD patients were significantly greater than those of group HD (P 〈0.05), the level of serum albumin, hemoglobin, the body mass index were significantly higher in group HDF&HD and HP&HD than those of group HD (P 〈0.05). The treatment with HDF&HD and HP&HD could significantly reduce the rates of dialysis complication compared with those of HD (P 〈0.05). The quality of life scores were significantly higher in group HDF&HD and HP&HD than those in group HD (P 〈0.05). Conclusion HDF and HP treatment are superior to the treatment of HD for maintaninance hemodialysis patients because they can clear part of serum β2-MG and leptin, can can improve nutrition status and dialysis adequacy reduce the rates of dialysis complication, and and life quality.
出处 《兰州大学学报(医学版)》 CAS 2010年第1期69-73,共5页 Journal of Lanzhou University(Medical Sciences)
基金 兰州市科技计划项目(07-1-83)
关键词 血液透析 血液透析滤过 血液灌流 Β2-微球蛋白 瘦素 透析并发症 营养状况 透析充分性 生存质量 hemodialysis hemodiafiltration hemoperfusion β2-microglobulin leptin dialysis complication nutrition status dialysis adequacy life quality
  • 相关文献

参考文献11

  • 1YAMASHITA A C. Mechanisms of solute and fluid removal in hemodiafiltration[J]. Contrib Nephrol, 2007, 158: 50-56.
  • 2王质刚.单病种吸附柱(罐)的研究进展[J].中国血液净化,2004,3(5):233-235. 被引量:26
  • 3MENAA C, ESSER E, SPRAGUE S M. Beta 2- microglobulin stimulates osteoclast formation[J]. Kidney Int, 2008, 73(11): 1 275-1 281.
  • 4FARAH-KLIBI F, FERCHICHI L, JARBOUI S, et al. Beta 2-microglobulin amyloidosis presenting as intestinal perforation in a haemodialysis patient[J]. Rev Med Interne, 2007, 28(4): 269-271.
  • 5SCHOLZE A, RATTENSPERGER D, ZIDEK W, et al. Low serum leptin predicts mortality in patients with chronic kidney disease stage[J]. Obesity (Silver Spring), 2007, 15(6): 1617-1622.
  • 6BOSSOLA M, TAZZA L, GIUNGI S, et al. Anorexia in hemodialysis patients: an update[J]. Kidney Int, 2006, 70(3): 417-422.
  • 7KAYARDI M, ICAGASIOGLU S, YILMAZ A, et al. Serum leptin levels and malnutrition in patients with chronic renal failure[J]. Saudi Med J, 2006, 27(4): 477-481.
  • 8NISHIZAWA Y, SHOJI T, ISHIMURA E. Body composition and cardiovascular risk in hemodialysis patients[J]. J Ren Nutr, 2006, 16(3): 241-244.
  • 9MANDOLFO S, BORLANDELLI S, IMBASCIATI E. Leptin and beta 2-microglobulin kinetics with three different dialysis modalities[J]. Int J Artif Organs, 2006, 29(10): 949-955.
  • 10KUTSUKI H. Beta 2-microglobulin-selective direct hemoperfusion column for the treatment of dialysis- related amyloidosis[J]. Biochim Biophys Acta, 2005, 1 753(1): 141-145.

二级参考文献14

  • 1[1]Sato T, Shoji H, Koga N. Endotoxin adsorption by polymyxin B immo bileized fiber column in patients with systemic inflammatory rssponse syndrome: The Japanese Experiense, Therapeutic Apheresis and Dialysis,2003,7(2) :252 - 258
  • 2[2]Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis:Endotoxin adsorption cartridge(Toraymyxin). Therapeutic Apheresis and Dialysis, 2003,7(1):108 - 114
  • 3[3]Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross- over comparison of three LDL - apheresis system in stain pretreated patients with familial hypercholesterolaemia. Athernsclerosis,2000,151(2) :493 - 7
  • 4[4]Ritter M. M, Parhofer K.G. Extracorporal low - density lipoprotein by innunoadsorption. Therapeutic Apheresis and Dialysis, 2003, 7 ( 3 ):370 - 372
  • 5[5]Nakaji S, Haynshi N. Adsorption for myasthenia gravis treatment:Medisorba MG - 50. Therapeutic Apheresis and dialysis, 2003,7 ( 1 ):78 - 84
  • 6[6]Hirata N, Kuriyama T, Yamawaki N. Immusorba TR and PH. Therapeutic Apheresis and Dialysis, 2003,7( 1 ) :85 - 90
  • 7[7]Bambauer R,Schiel R, Latza R,et al. LDL apheresis in clinical practice: long - term treatment of severe hyperlipidemia. Ther Apher, 1997,1(1): 49-51
  • 8[8]Brunton C, Varghese Z, Moorhead F. Lipoheresis in the nephrotic syndrome. kidney Int,1999,56(Suppl 71) :s6- s8
  • 9[9]Yamamoto T,Yammashita T. Low - density lioprotein apheresis using the liposorber system: feature and clinical benefits. Ther Apher, 1998, 2(1) :25- 30
  • 10[10]Bosch T, Keller C. Clinical effect of direct adorption of lipoprotein apheresis: Beyond cholesterol reduction. Therapeutic Apheresis and Dialysis, 2003, 7(3) :341 - 344

共引文献88

同被引文献133

引证文献20

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部